Clinical Trial Update: Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial update on innovative pneumococcal vaccine strategies for patients with ANCA-associated vasculitis receiving rituximab therapy; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Invasive Pneumococcal Infection

Drugs mentioned

• Pneumococcal vaccine (pneumococcal vaccine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Invasive Pneumococcal Infection | Phase 2 | Status: COMPLETED